Skip to main content
AVTX logo

AVTX · Avalo Therapeutics, Inc.

Track AVTX — free
$19.23 +0.23 (+1.21%) At close · Sep 4
Market Cap
$1.03B
Shares
53.63M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-18 CHRISTOPHER RYAN SULLIVAN 31,031
2026-08-17 CHRISTOPHER RYAN SULLIVAN 70,709
2026-08-17 CHRISTOPHER RYAN SULLIVAN 3,749
2026-08-17 MITTIE DOYLE 5,037
2026-08-11 JENNIFER RILEY 2,655
2026-08-10 MITTIE DOYLE 679
2026-06-02 JONATHAN GOLDMAN 42,833
2026-05-07 CHRISTOPHER SULLIVAN 18,606
2026-05-06 MITCHELL CHAN 3,167
2026-05-06 MITTIE DOYLE 54,508
2026-05-06 PAUL VARKI 92,771
2026-05-06 CHRISTOPHER SULLIVAN 47,000
2026-04-29 CHRISTOPHER SULLIVAN 16,915
2026-04-06 MITTIE DOYLE 65,800
2026-04-01 CHRISTOPHER SULLIVAN 15,959
2026-03-16 MITTIE DOYLE 29,529
Showing 1–16 of 16 filings
Key facts CIK 1534120 CUSIP 05338F306 13F (30d) 101 filings 101 filers Visit website Investor relations